Deka Bank Deutsche Girozentrale Gilead Sciences, Inc. Transaction History

Deka Bank Deutsche Girozentrale

$55.6 Billion
Q2 2024

A detailed history of Deka Bank Deutsche Girozentrale transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Deka Bank Deutsche Girozentrale holds 2,834,364 shares of GILD stock, worth $237 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares

2,834,364

Previous 2,057,579 37.75%

Holding current value

$237 Million

Previous $151 Million 29.92%

% of portfolio

0.35%

Previous 0.28%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$63.15 - $72.88 $49.1 Million - $56.6 Million	776,785 Added 37.75%	2,834,364 $196 Million
Q1 2024 Apr 24, 2024	SELL	$71.58 - $87.29 $9.99 Million - $12.2 Million	-139,559 Reduced 6.35%	2,057,579 $151 Million
Q4 2023 Jan 24, 2024	BUY	$73.27 - $83.09 $7.82 Million - $8.87 Million	106,694 Added 5.1%	2,197,138 $177 Million
Q3 2023 Nov 13, 2023	BUY	$73.94 - $80.67 $2.23 Million - $2.44 Million	30,186 Added 1.47%	2,090,444 $157 Million
Q2 2023 Jul 25, 2023	BUY	$76.01 - $86.7 $4.62 Million - $5.27 Million	60,830 Added 3.04%	2,060,258 $157 Million
Q1 2023 Apr 24, 2023	BUY	$77.31 - $88.08 $2.8 Million - $3.19 Million	36,225 Added 1.85%	1,999,428 $163 Million
Q4 2022 Feb 01, 2023	SELL	$62.32 - $89.47 $11 Million - $15.8 Million	-177,080 Reduced 8.27%	1,963,203 $166 Million
Q3 2022 Nov 02, 2022	BUY	$59.54 - $68.01 $13.8 Million - $15.7 Million	230,967 Added 12.1%	2,140,283 $135 Million
Q2 2022 Aug 03, 2022	BUY	$57.72 - $65.01 $2.59 Million - $2.92 Million	44,895 Added 2.41%	1,909,316 $119 Million
Q1 2022 Apr 28, 2022	BUY	$57.92 - $72.58 $23.3 Million - $29.2 Million	402,420 Added 27.53%	1,864,421 $112 Million
Q4 2021 Feb 02, 2022	SELL	$64.88 - $73.64 $2.33 Million - $2.65 Million	-35,923 Reduced 2.4%	1,462,001 $108 Million
Q3 2021 Oct 22, 2021	BUY	$67.69 - $73.03 $2.55 Million - $2.75 Million	37,629 Added 2.58%	1,497,924 $106 Million
Q2 2021 Aug 05, 2021	SELL	$63.47 - $69.35 $609,121 - $665,551	-9,597 Reduced 0.65%	1,460,295 $98.3 Million
Q1 2021 Apr 28, 2021	SELL	$60.0 - $68.46 $13.3 Million - $15.2 Million	-221,504 Reduced 13.1%	1,469,892 $96.5 Million
Q4 2020 Mar 12, 2021	BUY	$56.65 - $64.55 $692,263 - $788,801	12,220 Added 0.73%	1,691,396 $96.3 Million
Q3 2020 Oct 29, 2020	BUY	$62.1 - $78.08 $53.6 Million - $67.5 Million	863,916 Added 105.97%	1,679,176 $105 Million
Q2 2020 Aug 04, 2020	BUY	$72.34 - $84.0 $4.08 Million - $4.73 Million	56,343 Added 7.42%	815,260 $61.2 Million
Q1 2020 May 14, 2020	SELL	$62.63 - $80.22 $5.19 Million - $6.65 Million	-82,910 Reduced 9.85%	758,917 $58.1 Million
Q4 2019 Feb 04, 2020	SELL	$61.62 - $67.78 $20.7 Million - $22.8 Million	-336,340 Reduced 28.55%	841,827 $55.5 Million
Q3 2019 Nov 14, 2019	BUY	$62.51 - $69.0 $2.58 Million - $2.85 Million	41,233 Added 3.63%	1,178,167 $74.3 Million
Q2 2019 Aug 01, 2019	BUY	$61.87 - $69.38 $17.2 Million - $19.3 Million	277,857 Added 32.34%	1,136,934 $76.6 Million
Q1 2019 May 10, 2019	BUY	$62.53 - $70.05 $6.57 Million - $7.36 Million	105,100 Added 13.94%	859,077 $65.9 Million
Q4 2018 Feb 12, 2019	SELL	$60.54 - $79.0 $6.36 Million - $8.3 Million	-105,100 Reduced 12.23%	753,977 $47.7 Million
Q3 2018 Nov 09, 2018	BUY	$71.28 - $78.92 $944,103 - $1.05 Million	13,245 Added 1.57%	859,077 $0
Q2 2018 Aug 14, 2018	SELL	$64.88 - $75.68 $10.6 Million - $12.4 Million	-163,574 Reduced 16.2%	845,832 $59.9 Million
Q1 2018 May 03, 2018	SELL	$72.84 - $88.8 $6.26 Million - $7.64 Million	-85,981 Reduced 7.85%	1,009,406 $76 Million
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $108,717 - $127,618	1,528 Added 0.14%	1,095,387 $80.6 Million
Q3 2017 Nov 06, 2017	BUY	$72.11 - $85.47 $78.9 Million - $93.5 Million	1,093,859	1,093,859 $80.5 Million

Others Institutions Holding GILD

# of Institutions

1,879

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $105B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

News

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.

Account

Deka Bank Deutsche Girozentrale Gilead Sciences, Inc. Transaction History